摘要:
The invention relates to solid pharmaceutical preparations which have a long-lasting action and are for dihydropyridines in the form of a press coated tablet, and a process for their preparation.
摘要:
New compounds of the formula ##STR1## in which R.sub.1 is an allylamino, acetylamino or propionylamino radical,R.sub.2 is hydrogen or a 2-methoxyethoxy or ethoxy radical,R.sub.3 is hydrogen or a sulphamoyl radical, andR.sub.4 is hydrogen,and of the formula ##STR2## in which R.sub.1 is a halogen atom or a free or substituted hydroxyl, sulphhydryl or amino group,R.sub.2 is a hydrogen atom, an alkyl radical, a halogen atom, or a free or substituted hydroxyl, sulphhydryl or amino group,R.sub.3 and R.sub.4 each independently is hydrogen, alkyl, hydroxyl, alkoxy, sulphonamido or halogen, with the proviso that R.sub.2, R.sub.3 and R.sub.4 are hydrogen when R.sub.1 is hydroxyl,exhibit anti-inflammatory activity.
摘要:
The present invention provides, inter alia, antiphlogistically effective agents, including pharmaceutical compositions containing said agents. Also included are methods for the use of said agents. The active compounds are those of the formula ##STR1## or an ester thereof, in which X denotes a hydrogen atom, an alkyl group, an alkoxy group, an alkylthio group, an alkylsulphinyl or alkylsulphonyl group or a hydroxyl or mercapto group,Y denotes a grouping ##STR2## in which R denotes a hydrogen atom or an alkyl group, andZ denotes a hydroxyl group or an alkoxy or alkylthio group, at least one of the substituents X or Z in each case denoting a sulphur-containing radical.
摘要:
A safety switch (1) has a support (2) of an elastomer and a through-going cavity (3). Within the cavity (3) are arranged electrical conductors (4) and (5) which in a rest condition are arranged at a distance (9) from one another. The electrical conductors (4, 5) are each formed as a strip of carbon fibers and have one broad side (6) and (7) vulcanized to the support (2) either directly or by way of a coupling layer (8). Substantially perpendicular pressure (12, 13) on the safety switch (1) leads to the deformation of the support (2) and eventually to the contact of the electrical conductors (4, 5) with each other. By this means, safety functions are controlled.
摘要:
Hydrochloric acid having a substantially constant HCl content of 20 to 36% is produced continuously by removing hydrogen chloride from hot combustion gas. To this end, hot combustion gas containing 1 to 10% by volume of HCl and steam, this gas being obtained by the joint combustion of off-gases containing chlorinated hydrocarbons and liquid residues of chlorinated hydrocarbons, is introduced into a quenching zone, and quenched therein, down to a temperature lower than its dew point, by means of cooled hydrochloric acid containing hydrogen chloride in a concentration of 20 to 36%, which concentration corresponds to the concentration of the hydrochloric acid which is to be produced. The resulting gas-liquid mixture is separated in an absorption cooling zone into cooled hydrochloric acid and cooled combustion gas containing 0.1 to 1% by volume of HCl. The cooled hydrochloric acid is introduced into a reservoir zone capable of receiving a multiple of the quantity of hydrochloric acid produced per hour, and recycled from the said reservoir zone to the quenching zone. Additional 20 to 36% hydrochloric acid produced is taken out of the quenching cycle.
摘要:
Off-gases and liquid residues containing chlorinated hydrocarbons, are subjected to joint combustion by forming a mist comprising a mixture of off-gases and atomized liquid residues, the latter being atomized by means of air and/or steam, and directing this mist into a preheated combustion chamber lined with refractory bricks. The mixture is introduced into the combustion chamber jointly with combustion air through a burner having four feed pipes arranged coaxially with respect to each other and terminating in conically tapered outlets, the three outer feed pipes defining three separate and coaxial annular zones around the innermost feed pipe. The liquid residue fed in and burnt is used in a quantity sufficient to maintain in the combustion chamber a predetermined maximum temperature which is not above the range 1200.degree. to 1800.degree. C., and which is compatible with the refractory properties of the brick lining of the combustion chamber. The resulting hot combustion gases are withdrawn from the combustion chamber, quenched with water, and hydrochloric acid is recovered from the resulting aqueous solution.
摘要:
An identification stamp comprises a housing (1, 2) having a transferrable marking (11) at the housing end face and an adjustment element (3) which is inserted in the housing (1, 2) in an adjustable manner and which is provided with a transferrable marking (31) at its end face. When the adjustment element (3) is adjusted with respect to the housing (1, 2), the marking (11) is adjusted relative to the marking (31). An engagement means (33, 13) is made of at least one detent nose (33), which is integrally arranged on the adjustment element (3) in the axial direction in a protruding manner and which engages with one of a plurality of locking grooves (13) integrally arranged on the housing (1) in the axial direction in a recessed manner.
摘要:
The invention relates to pharmaceutical compositions containing as an active ingredient a dipeptide or an acid salt or a base addition salt thereof or a stereoisomer thereof, said dipeptide being those of the formulaR--Phe--Trp--R.sub.1in whichPhe denote the radical ##STR1## Trp denotes the radical ##STR2## R denotes a hydrogen atom or a C.sub.1 to C.sub.6 optionally substituted alkanoyl group andR.sub.1 denotes a hydroxyl, C.sub.1 to C.sub.4 alkoxy, amino, C.sub.1 to C.sub.4 alkylamino or di-C.sub.1 to C.sub.4 alkylamino group.
摘要:
Dehydrooligopeptides, some of which are known, demonstrate histolytic and tumor-resolving activity and may be used in medicaments causing the lysis of animal tissues and/or tumors in warm-blooded animals.
摘要:
The present invention provides, inter alia, antiphlogistically effective agents, including pharmaceutical compositions containing said agents. Also included are methods for the use of said agents. The active compounds are those of the formula ##STR1## or an ester thereof, in which X denotes a hydrogen atom, an alkyl group, an alkoxy group, an alkylthio group, an alkylsulphinyl or alkylsulphonyl group or a hydroxyl or mercapto group,Y denotes a grouping ##STR2## in which R denotes a hydrogen atom or an alkyl group, andZ denotes a hydroxyl group or an alkoxy or alkylthio group, at least one of the substituents X or Z in each case denoting a sulphur-containing radical.